HHS (NIH, CDC, FDA) Solicitations
The 2018 Omnibus Grant Solicitations of the NIH, CDC, and FDA have been issued for the SBIR and STTR (NIH only) programs (due April 5, 2018), implementing new application forms (FORMS-E), as well as changes to how applications involving clinical trials are submitted. FORMS-E consolidate human subjects and inclusion enrollment report information into a new PHS Human Subjects and Clinical Trials Information form. The new form also expands clinical trial data collection. NIH now requires all applications proposing work that meets NIH’s definition of a clinical trial to be submitted to a Funding Opportunity Announcement (FOA) that specifically states it accepts clinical trials. As a result, there are now four Omnibus parent solicitations, two not allowing clinical trials (SBIR FOA; STTR FOA), and two requiring clinical trials (SBIR FOA; STTR FOA). Certain NIH Institutes and Centers (NCI, NEI, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NLM, FIC, NCATS) will not participate in the Parent R01 Requiring a Clinical Trial, and will release their own FOAs for proposals involving clinical trials.
Current DoD SBIR and STTR Broad Agency Announcements (BAA) are open and are due on February 7. The next round of BAAs will be released on April 20, open on May 22, and close on June 20. The list of topics issued by participating components can be viewed here.
The NASA 2018 General Solicitation is now open through March 9. Notably, the performance period for STTR Phase I contracts has been increased to 13 months. The Technical Proposal now has 10 parts instead of 11, and page limits are the same for SBIR and STTR applications (19 for Phase I and 46 for Phase II). The Briefing Chart now requires deliverables to be indicated. SBIR and STTR subtopics have been combined into a single list and can be viewed here.